PapersPMID:27470399
Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial.
- 01 · findings
- 2
- 02 · compound
- 1
- 03 · endpoints
- 2
- 04 · null
- 0
curcumin- Dose studied, every finding
- curcumin 1 g/day for 8 weeks
- Population, every finding
- adults with metabolic syndrome (NCEP-ATPIII criteria), post-hoc analysis
What moved
2 findingsHow to read these marks →curcumin — decreases interleukin-6 concentration
very limitedFindingreplicated ×8
“Between-group comparison suggested significantly greater reductions in serum concentrations of TNF-α, IL-6, TGF-β and MCP-1 in the curcumin versus placebo group (p<0.001).”
Quoted verbatim from Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial. - Study
- RCT
- Duration
- 8 weeks
curcumin — decreases tumour necrosis factor alpha concentration
very limitedFindingreplicated ×6
“Between-group comparison suggested significantly greater reductions in serum concentrations of TNF-α, IL-6, TGF-β and MCP-1 in the curcumin versus placebo group (p<0.001).”
Quoted verbatim from Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial. - Study
- RCT
- Duration
- 8 weeks
Study record
- Read under
- curcumin
- Design
- randomised controlled trial
- Species
- human
- Population
- males and females with metabolic syndrome (NCEP ATP III criteria); post-hoc analysis
- Participants
- 117
- Comparator
- placebo
- Duration
- 56 days
- Endpoints measured
- 6
- Record
- extracted
- Readings recorded
- 2